Quintiles Outcome Leadership

President

Richard Gliklich, MD

Dr. Richard Gliklich is President of Quintiles Outcome.

Dr. Gliklich focuses on clinical research on the effectiveness, safety, and quality of care. Dr. Gliklich was principal investigator and senior editor of the landmark publication by the U.S. Agency for Healthcare Research and Quality (AHRQ) handbook "Registries for Evaluating Patient Outcomes: A User's Guide." Some of the programs developed by Dr. Gliklich include the American Heart Association's Get With The Guidelines^SM registries in cardiovascular disease, heart failure, and stroke, which involve more than 2,500 U.S. hospital and more than one million patients, and received the 2004 Innovation Award from the U.S. Department of Health and Human Services and the 2007 eHealth Initiative Award.

Dr. Gliklich is a frequently invited speaker on post-approval programs and registries, and has served on numerous advisory boards. He is the director of an annual international conference at Harvard, focusing on post-approval studies, registries, and risk management (Post-Approval Summit^®). He has authored more than 90 academic publications, with a large number of articles on patient registries and patient reported outcomes. Dr. Gliklich is the editor of a textbook on the practical value of real-world data in medical practice, "Profiting from Quality: Outcomes strategies for medical practice," published by Jossey-Bass, Inc., in 1999. He is a Principal Investigator (PI) for the Outcome DEcIDE Center under the Agency for Healthcare Research and Quality's Effective Healthcare Program. In 2010, Dr. Gliklich was recognized by the trade journal PharmaVoice as one of the 100 most inspiring people in the pharmaceutical and life sciences industry.

A graduate of Yale University and Harvard Medical School, Dr. Gliklich is also a former Charles A. Dana Scholar at the University of Pennsylvania School of Medicine in outcomes research. In addition to his work at Quintiles Outcome, Dr. Gliklich is a practicing physician and a Professor at Harvard Medical School.

Global Head of Scientific Affairs

Nancy Dreyer, MPH, PhD

Dr. Nancy Dreyer is Chief of Scientific Affairs and Senior Vice President at Quintiles Outcome. She leads a team of researchers who design, conduct, and interpret observational research on comparative effectiveness and safety, and quality improvement programs.

Her recent accomplishments include serving as a senior editor and co‑author of the handbook, “Registries for Evaluating Patient Outcomes: A User’s Guide,” commissioned by the US Agency for Healthcare Research and Quality. This handbook was first published in 2007 and then updated in 2010. She leads the GRACE Initiative which is developing guidance on Good Research Practices for Observational Studies of Comparative Effectiveness (see www.graceprinciples.org), and in 2009 joined the Steering Committee for the European Medicines Agency’s PROTECT Project for the Innovative Medicines Initiative. In 2007 Dreyer was recognized by the trade journal, Pharmavoice as one of the 100 most inspiring people in the pharmaceutical and life sciences industry.

Dr. Dreyer has more than 25 years of experience in epidemiologic research. She trained at the University of North Carolina in Chapel Hill, earning a masters degree and doctorate in Epidemiology. She was CEO of Epidemiology Resources, Inc., a job she held from the company’s inception through its acquisition 20 years later by UnitedHealth Group. In that role, she launched and published the peer‑reviewed journal, Epidemiology, for its first ten years, and led the New England Epidemiology Institute, a summer program which trained more than 5000 scientists through collaboration with international medical schools and schools of public health. Dr. Dreyer is a Fellow and Board Member of the International Society of Pharmacoepidemiology.